J&J raises US prices on around two dozen drugs


Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
Read More at J&J raises US prices on around two dozen drugs
Source: CNBC